- Report
- November 2023
- 200 Pages
Global
From €3195EUR$3,599USD£2,749GBP
- Report
- November 2023
- 173 Pages
Global
From €3195EUR$3,599USD£2,749GBP
- Report
- October 2023
- 188 Pages
Global
From €3195EUR$3,599USD£2,749GBP
- Report
- September 2023
- 200 Pages
Global
From €3195EUR$3,599USD£2,749GBP
- Report
- April 2023
- 160 Pages
Global
From €4393EUR$4,949USD£3,781GBP
- Report
- July 2022
- 85 Pages
Global
From €1775EUR$2,000USD£1,528GBP
- Report
- June 2022
- 43 Pages
Global
From €1775EUR$2,000USD£1,528GBP
- Report
- June 2022
- 43 Pages
Global
From €1775EUR$2,000USD£1,528GBP
- Report
- February 2022
- 106 Pages
Global
From €1775EUR$2,000USD£1,528GBP
- Report
- July 2024
- 134 Pages
Global
From €2219EUR$2,500USD£1,910GBP
- Report
- July 2024
- 139 Pages
Global
From €2219EUR$2,500USD£1,910GBP
- Report
- July 2024
- 130 Pages
Global
From €2219EUR$2,500USD£1,910GBP
- Report
- April 2024
- 172 Pages
Global
From €2219EUR$2,500USD£1,910GBP
- Report
- January 2024
- 167 Pages
Global
From €2219EUR$2,500USD£1,910GBP
- Report
- August 2025
China
From €1860EUR$2,095USD£1,600GBP
€3542EUR$3,990USD£3,048GBP
- Report
- August 2025
United Kingdom
From €1860EUR$2,095USD£1,600GBP
€3542EUR$3,990USD£3,048GBP
- Report
- March 2024
- 111 Pages
North America
From €1331EUR$1,500USD£1,146GBP
- Report
- March 2024
- 117 Pages
Africa, Middle East
From €1331EUR$1,500USD£1,146GBP
- Report
- March 2024
- 223 Pages
Global
From €3195EUR$3,600USD£2,750GBP
- Report
- March 2024
- 115 Pages
Europe
From €1331EUR$1,500USD£1,146GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more